Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.652, 2012-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PCV-13 vaccination proves its worth in a US pandemic . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 641, 2011-01 ,pp. :
Access to resources
Recommend
Universal PCV13 proves its worth in Taiwan
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 648, 2012-01 ,pp. :
Influenza vaccination programme worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. :
Meningococcal serogroup C vaccination programme well worth it in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
Current PCV-7 vaccination not cost effective in the Netherlands
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 606, 2010-01 ,pp. :